BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12629757)

  • 1. [Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease].
    Hisatome I; Ogino K; Igawa O; Shigemasa C
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():403-9. PubMed ID: 12629757
    [No Abstract]   [Full Text] [Related]  

  • 2. [Other antihyperuricemic agents].
    Ogino K; Igawa O; Hisatome I
    Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-angiotensin system blockers.
    Berni A; Boddi M; Fattori EB; Cecioni I; Berardino S; Montuschi F; Chiostri M; Poggesi L
    Am J Hypertens; 2010 Jun; 23(6):675-80. PubMed ID: 20203626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients.
    Kostka-Jeziorny K; Uruski P; Tykarski A
    Blood Press; 2011 Apr; 20(2):104-10. PubMed ID: 21405957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and future therapeutic options for the management of gout.
    Whelton A
    Am J Ther; 2010; 17(4):402-17. PubMed ID: 20562597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
    Mazzali M; Kanellis J; Han L; Feng L; Xia YY; Chen Q; Kang DH; Gordon KL; Watanabe S; Nakagawa T; Lan HY; Johnson RJ
    Am J Physiol Renal Physiol; 2002 Jun; 282(6):F991-7. PubMed ID: 11997315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanism in biological transport in the kidney: Urate transporter URAT1].
    Hosoyamada M; Shibasaki T; Ichida K
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():176-9. PubMed ID: 16523883
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperuricemia induced by diuretics in hypertensive patients. Curative and preventive treatment with benziodarone].
    Lagrue G; Ménard J; Safar M; Schlotterer P; Oliver-Martin F; Kazandjian M; Milliez P
    Therapeutique; 1971 Nov; 47(9):761-5. PubMed ID: 5147554
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lozartan potential in hyperuricemia correction].
    Ter Arkh; 2011; 83(10):45-8. PubMed ID: 22185025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout: on the brink of novel therapeutic options for an ancient disease.
    Bieber JD; Terkeltaub RA
    Arthritis Rheum; 2004 Aug; 50(8):2400-14. PubMed ID: 15334451
    [No Abstract]   [Full Text] [Related]  

  • 11. [Uricosuric effect of benzbromaronum on a model of pyrazine amide-induced hyperuricemia].
    Kropp R
    Med Klin; 1970 Aug; 65(32):1448-50. PubMed ID: 5523876
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials of uric acid lowering for coronary heart disease risk reduction.
    Simon JA
    Am J Med; 2006 Apr; 119(4):e5; author reply e7. PubMed ID: 16564763
    [No Abstract]   [Full Text] [Related]  

  • 13. Approach to the treatment of hyperuricemia.
    Poon SH; Hall HA; Zimmermann B
    Med Health R I; 2009 Nov; 92(11):359-62. PubMed ID: 19999894
    [No Abstract]   [Full Text] [Related]  

  • 14. Uric acid: role in cardiovascular disease and effects of losartan.
    Alderman M; Aiyer KJ
    Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging uricosurics for gout.
    Terkeltaub R
    Expert Rev Clin Pharmacol; 2017 Mar; 10(3):247-249. PubMed ID: 27937050
    [No Abstract]   [Full Text] [Related]  

  • 16. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary hyperuricemia in Down's syndrome].
    Okabe H; Mizuguchi M
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():318-22. PubMed ID: 12629739
    [No Abstract]   [Full Text] [Related]  

  • 18. The physiologic approach to hyperuricemia.
    Rastegar A; Thier SO
    N Engl J Med; 1972 Mar; 286(9):470-6. PubMed ID: 4550616
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum uric acid and the risk of hypertension and chronic kidney disease.
    Feig DI
    Curr Opin Rheumatol; 2014 Mar; 26(2):176-85. PubMed ID: 24419747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of gout and hyperuricemia.
    Wisner DE; Simkin PA
    Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.